Related Experiment Video
Updated: Jun 20, 2026

Three-Dimensional Cell Culture Models to Investigate the Epithelial Barrier in Eosinophilic Esophagitis
Published on: May 10, 2024
Galectin-10, eosinophils, and celiac disease.
Valli De Re1, Maria Paola Simula, Renato Cannizzaro
1Experimental and Clinical Pharmacology Unit, Istituto Di Ricovero e Cura a Carattere Scientifico, Aviano, Italy. vdere@cro.it
Researchers identified galectin-10 as a novel marker for celiac disease (CD) tissue damage. This finding relates galectin-10 expression to disease severity and eosinophil presence, suggesting new therapeutic targets.
Area of Science:
- Gastroenterology
- Immunology
- Molecular Biology
Background:
- Celiac disease (CD) is an autoimmune disorder triggered by gluten in genetically susceptible individuals.
- The precise pathogenesis and markers for tissue damage in CD require further elucidation.
- Understanding protein expression patterns can offer insights into disease mechanisms.
Purpose of the Study:
- To investigate protein expression patterns in gut biopsies of celiac disease patients.
- To identify novel biomarkers for assessing CD histological grade and tissue damage.
- To explore the role of specific proteins in CD pathogenesis.
Main Methods:
- Analysis of protein expression in gut biopsies from CD patients with varying histological grades (Marsh 0, I-II, III) and healthy controls.
- Correlation of protein expression with histological inflammatory degree and eosinophil counts.
- Genotyping for human leukocyte antigen DQ2/8 variants in all CD subjects.
Main Results:
- Galectin-10 expression was significantly associated with the histological grade of celiac disease (P = 0.0092).
- Galectin-10 levels correlated positively with the number of eosinophils in gut lesions (P = 0.0040).
- All celiac disease patients carried human leukocyte antigen DQ2/8 variants.
Conclusions:
- Galectin-10 emerges as a novel potential biomarker for evaluating tissue damage in celiac disease.
- Eosinophils represent a potential therapeutic target for managing CD-related inflammation.
- The study provides new insights into the molecular alterations underlying CD pathogenesis.
More Related Videos
Related Concept Videos
Inflammatory Bowel Disease III: Crohn's Disease
Amebiasis
Selectins
Asthma I: Introduction
Other Disorders of Digestive System
Proteoglycans

